803 related articles for article (PubMed ID: 8543829)
61. Circulating immune complexes and complement activation in primary biliary cirrhosis.
Wands JR; Dienstag JL; Bhan AK; Feller ER; Isselbacher KJ
N Engl J Med; 1978 Feb; 298(5):233-7. PubMed ID: 619265
[TBL] [Abstract][Full Text] [Related]
62. Complementing antibody profiles: assessing antibody function on antigen microarrays.
Prechl J; Szittner Z; Papp K
Immunol Lett; 2012 Mar; 143(1):101-5. PubMed ID: 22306105
[TBL] [Abstract][Full Text] [Related]
63. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
64. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.
Kubagawa H; Bertoli LF; Barton JC; Koopman WJ; Mestecky J; Cooper MD
J Immunol; 1987 Jan; 138(2):435-9. PubMed ID: 3794339
[TBL] [Abstract][Full Text] [Related]
65. Complement and immunoglobulin levels in Ilorin Nigeria, and environ.
Oyeyinka GO; Aiyedun BA; Erasmus RT; Adewoye HO; Adetoro OO; Adedoyin MA
Afr J Med Med Sci; 1995 Mar; 24(1):9-16. PubMed ID: 7495207
[TBL] [Abstract][Full Text] [Related]
66. Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
Pfaffenbach G; Lamm ME; Gigli I
J Exp Med; 1982 Jan; 155(1):231-47. PubMed ID: 7054357
[TBL] [Abstract][Full Text] [Related]
67. Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity.
Wang L; Young DC
Ann Clin Lab Sci; 2001 Jul; 31(3):274-8. PubMed ID: 11508831
[TBL] [Abstract][Full Text] [Related]
68. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
69. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.
Kinsella TD; Espinoza L; Vasey FB
J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743
[TBL] [Abstract][Full Text] [Related]
70. Alterations in immunoglobulin & complement levels in chronic obstructive pulmonary disease.
Chauhan S; Gupta MK; Goyal A; Dasgupta DJ
Indian J Med Res; 1990 Aug; 92():241-5. PubMed ID: 2228068
[TBL] [Abstract][Full Text] [Related]
71. Circulating immune complexes containing IgG, IgA and IgM in patients with myocardial infarction: detection with C1qSP and anti C3SP.
Triolo G; Traina M; Giardina E; Galluzzo A; Rinaldi A; Raineri A
J Clin Lab Immunol; 1984 Jan; 13(1):35-9. PubMed ID: 6609236
[TBL] [Abstract][Full Text] [Related]
72. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
73. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
[TBL] [Abstract][Full Text] [Related]
74. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
75. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
76. Phagocytosis of immune complexes mediated by IgM and C3 receptors by macrophages from mice treated with glycogen.
Mantovani B
J Immunol; 1981 Jan; 126(1):127-30. PubMed ID: 7451963
[TBL] [Abstract][Full Text] [Related]
77. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
Ejzemberg R; Borsos T
J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
[TBL] [Abstract][Full Text] [Related]
78. Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.
Böttger EC; Hoffmann T; Hadding U; Bitter-Suermann D
J Clin Invest; 1986 Sep; 78(3):689-95. PubMed ID: 2427541
[TBL] [Abstract][Full Text] [Related]
79. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.
Lukas TJ; Muñoz H; Erickson BW
J Immunol; 1981 Dec; 127(6):2555-60. PubMed ID: 7299136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
